Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
125 participants
OBSERVATIONAL
2021-10-21
2024-09-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
VIVO Mapping Protocol
NCT03994068
IVTCC 2.0: A Prospective Multicenter Ventricular Tachycardia Catheter Ablation Registry
NCT04520347
Ventricular Tachycardia Cohort
NCT07149701
Achieving Conduction System Activation With Leadless Left Ventricular Endocardial Pacing
NCT05659680
Modification of the Local Abnormal Ventricular Activity Only
NCT05331716
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VIVO
VIVO is a per-procedural planning tool designed to non-invasively identify the origin of a ventricular arrhythmia.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who have previously had contrast cardiac imaging or will have cardiac imaging ordered per standard of care
* Patients will be selected without regard to gender.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Catheter Precision. Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andre Ng, MD
Role: PRINCIPAL_INVESTIGATOR
Glenfield University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mater Private Hospital
Dublin, , Ireland
Mazzoni Hospital
Ascoli Piceno, , Italy
University Medical Center Groningen
Groningen, , Netherlands
Erasmus Medical Center
Rotterdam, , Netherlands
La Luz Hospital
Lisbon, , Portugal
Glenfield University Hospital
Leicester, , United Kingdom
Royal Brompton Hospital
London, , United Kingdom
John Radcliffe University Hospital
Oxford, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
02-0521-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.